ArticleInternational journal of chronic obstructive pulmonary disease2013
Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure.
Article in International journal of chronic obstructive pulmonary disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 41 citations in OpenAlex.
- Prescription and use of ward-delivered nasal high-flow oxygen and non-invasive ventilation for people with acute respiratory failure.Internal medicine journal · 2026Article
- Cost-utility analysis of home mechanical ventilation compared to hospital settings in patients with chronic obstructive pulmonary disease.Cost effectiveness and resource allocation : C/E · 2026Article
- Role of Non-Invasive Ventilation in Elderly Patients: Therapeutic Opportunity or Medical Futility? An Updated Narrative Review.Medicina (Kaunas, Lithuania) · 2025Review
- Clinical factors associated with the use of NIV in the pre-hospital setting in adult patients treated for acute COPD exacerbation: a single-center retrospective cohort study.BMC emergency medicine · 2025Article
- Long-term outcomes in patients with COPD treated with non-invasive ventilation for acute hypercapnic respiratory failure.Irish journal of medical science · 2024Article
- Acute COPD exacerbation treatment with noninvasive ventilation.Scientific reports · 2023Article
- Long-Term Mortality following Acute Noninvasive Ventilation for Obesity-Related Respiratory Failure: A Retrospective Single-Centre Study.Canadian respiratory journal · 2023Article
- Predictors for long-term mortality in COPD patients requiring non-invasive positive pressure ventilation for the treatment of acute respiratory failure.The clinical respiratory journal · 2020Article
- NIV for acute respiratory failure in COPD: high in-hospital mortality is determined by patient selection.European clinical respiratory journal · 2019Article
- Mindfulness-Based Symptom and Stress Management Apps for Adults With Chronic Lung Disease: Systematic Search in App Stores.JMIR mHealth and uHealth · 2018Review
- Noninvasive ventilation in stable hypercapnic COPD: what is the evidence?ERJ open research · 2018Review
- Home noninvasive ventilatory support for patients with chronic obstructive pulmonary disease: patient selection and perspectives.International journal of chronic obstructive pulmonary disease · 2018Review
- One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease.Journal of thoracic disease · 2017Article
- Trends in assisted ventilation and outcome for obstructive pulmonary disease exacerbations. A nationwide study.PloS one · 2017Article
- Can patients with moderate to severe acute respiratory failure from COPD be treated safely with noninvasive mechanical ventilation on the ward?International journal of chronic obstructive pulmonary disease · 2016Observational
- Assisted ventilation in COPD - association between previous hospitalizations and mortality.International journal of chronic obstructive pulmonary disease · 2016Article
- Severe hypoalbuminemia is a strong independent risk factor for acute respiratory failure in COPD: a nationwide cohort study.International journal of chronic obstructive pulmonary disease · 2015Article
- Noninvasive ventilation in acute respiratory failure.International journal of chronic obstructive pulmonary disease · 2014Review
- Are patients with COPD treated with NIV in accordance with national guidelines? An internal audit.European clinical respiratory journal · 2014Article
- Predicting survival after acute exacerbation chronic obstructive pulmonary disease (ACOPD): is long-term application of noninvasive ventilation the last life guard?International journal of chronic obstructive pulmonary disease · 2013Article
Corrections and comments
- Commented on by
- Commented on byAuthors’ reply.2013
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
unlabelledImplementation of noninvasive ventilation (NIV) as an add-on treatment has been routinely used in a non-intensive care setting since 2004 for patients with chronic obstructive pulmonary disease (COPD) and acute hypercapnic respiratory failure at a university hospital in Denmark. Although randomized controlled trials show lowered mortality rates in highly selected patients with acute exacerbation and respiratory failure, there are only few reports on long-term survival after receiving NIV. We present long-term all-cause mortality data from patients receiving NIV for the first time.
methodData from medical records were retrospectively retrieved from all patients receiving NIV for the first time after being admitted acutely to an acute medical ward and further transfer to a respiratory ward with respiratory failure and a diagnosis of COPD in the period January 1, 2005 to December 31, 2007; patients were followed until January 2012. Demographic data collected included age, sex, diagnoses at discharge, and, when present, FEV1; a "not-to-intubate" order was also registered when listed.
resultsIn total, 253 patients (143 female, 110 male) received NIV for the first time. The median age was 72 years (range 46-91 years). The 30-day mortality rate was 29.3%. The 5-year survival rate was 23.7%. Women showed a trend towards better survival than men (25.7% vs 19.2%, P = 0.25), and the trend was even more pronounced for patients with COPD.
conclusionThe mortality rate of patients receiving NIV is high, as expected in a real-life setting, but with a 5-year survival rate of 23.7% with a trend towards more female than male long-term survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.